AI assistant
Sending…
Terns Pharmaceuticals, Inc. — Director's Dealing 2024
May 2, 2024
32559_dirs_2024-05-02_28f2bd4d-d161-4304-90b8-cfa92b0b7205.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Terns Pharmaceuticals, Inc. (TERN)
CIK: 0001831363
Period of Report: 2024-04-22
Reporting Person: Jung Melita Sun (N/A)